Application Nr Approved Date Route Status External Links
ANDA079028 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Galantamine Hydrobromide Extended-Release Capsules Are Indicated For The Treatment Of Mild To Moderate Dementia Of The Alzheimer’s Type.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Galantamine Hydrobromide GALANTAMINE HYDROBROMIDE ZINC491073

Comments